tirzepatide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42560457
Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis.
Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis.
- 저자
- Wiktoria Pałka, Paweł Moćko, Katarzyna Śladowska, Przemysław Holko, Paweł Kawalec
- 저널
- Journal of endocrinological investigation
- 공개일
- 2026 Aug 06
- 연구 유형
- 기타
- DOI
- 10.1007/s40618-026-03006-y
문헌 요약
The rapid rise in overweight and obesity worldwide underscores the need for comparative evidence on long-term pharmacotherapy. The recent introduction of a 7.2 mg maintenance dose of semaglutide warrants particular attention. We assessed the efficacy and safety of glucagon-like peptide-1 (GLP-1) and GLP-1/glucose-dependent insulinotropic polypeptide (GIP)…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.